Harrow, Inc. Payments of Financing Costs
Harrow, Inc. (HROW) reported Payments of Financing Costs of $53.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2020-03-13
- Harrow, Inc. payments of financing costs for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Harrow, Inc. payments of financing costs for the quarter ending 2018-09-30 was $0.00.
- Harrow, Inc. payments of financing costs for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Harrow, Inc. payments of financing costs for the quarter ending 2018-03-31 was $53.00K, a 6.00% increase year-over-year.
- Harrow, Inc. payments of financing costs for fiscal 2018 was $53.00K, a 74.27% decline from fiscal 2017.
- Harrow, Inc. payments of financing costs for fiscal 2017 was $206.00K, a 5.64% increase from fiscal 2016.
- Harrow, Inc. payments of financing costs for fiscal 2016 was $195.00K, a 44.44% increase from fiscal 2015.
- Harrow, Inc. payments of financing costs for fiscal 2015 was $135.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $53.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $53.00K 10-Q · filed 2019-11-13 | $158.00K derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $53.00K 10-Q · filed 2019-08-14 | $158.00K derived: sum of 3 quarters · filed 2019-08-14 | $158.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $53.00K 10-Q · filed 2019-05-09 | $158.00K derived: sum of 2 quarters · filed 2019-05-09 | $158.00K derived: sum of 3 quarters · filed 2019-05-09 | $209.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $105.00K derived: sum of 2 quarters · filed 2019-03-12 | $156.00K derived: sum of 3 quarters · filed 2019-03-12 | $206.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $51.00K derived: sum of 2 quarters · filed 2018-11-13 | $101.00K 10-Q · filed 2018-11-13 | $151.00K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $101.00K 10-Q · filed 2018-08-06 | $151.00K derived: sum of 3 quarters · filed 2018-08-06 | $199.00K derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $50.00K 10-Q · filed 2018-05-15 | $100.00K derived: sum of 2 quarters · filed 2018-05-15 | $148.00K derived: sum of 3 quarters · filed 2018-05-15 | $197.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $98.00K derived: sum of 2 quarters · filed 2018-03-08 | $147.00K derived: sum of 3 quarters · filed 2018-03-08 | $195.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $97.00K derived: sum of 2 quarters · filed 2017-11-14 | $145.00K 10-Q · filed 2017-11-14 | $193.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $97.00K 10-Q · filed 2017-08-10 | $145.00K derived: sum of 3 quarters · filed 2017-08-10 | $192.00K derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $48.00K 10-Q · filed 2017-05-10 | $96.00K derived: sum of 2 quarters · filed 2017-05-10 | $143.00K derived: sum of 3 quarters · filed 2017-05-10 | $108.00K derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $95.00K derived: sum of 2 quarters · filed 2017-03-21 | $60.00K derived: sum of 3 quarters · filed 2017-03-21 | $135.00K 10-K · filed 2017-03-21 |
| 2015-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $12.00K derived: sum of 2 quarters · filed 2016-11-14 | $87.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $40.00K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $75.00K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |